Southampton research team secures £2.25 million to help improve immunotherapy treatments for cancer
Cancer immunotherapy research in Southampton has been given a boost thanks to new funding by Cancer Research UK.
Cancer immunotherapy research in Southampton has been given a boost thanks to new funding by Cancer Research UK.
Professor Mark Cragg from the Centre for Cancer Immunology is part of a review of recent discoveries on how antibodies work in our bodies.
A scientist at the Centre for Cancer Immunology has been involved in a study that shows, for the first time, the real-world vaccine responses and infection outcomes in clinically at-risk patients with a range of immunocompromised or immunosuppressed conditions.
Clinician scientists in Southampton have shown a rare form of cancer can be treated with a drug that’s already available on the NHS.
Scientists and researchers from the Centre for Cancer Immunology have been presenting their work at several conferences across the globe over the past few weeks.
A professor, based at the Centre for Cancer Immunology, has been appointed to a national role aiming to improve and expand cancer services in the UK.
Scientists at the Centre for Cancer Immunology are to begin a new study to better understand why certain natural killer T cells are more effective against cancer than others.
The Southampton Clinical Trials Unit (SCTU) based at the Centre for Cancer Immunology has been given a multi-million-pound boost by Cancer Research UK.
A Guernsey student is getting ready to start a four-year project, aiming to develop a vaccine that will fight cancer.
The Antibody and Vaccine Group (AVG) at the Centre for Cancer Immunology has been recognised for its innovative research by the British Society for Immunology.